Global Apoptosis Assays Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 3,315.70 Million |
 Market Size (Forecast Year) |
USD 6,558.41 Million |
 CAGR |
% |
| Major Markets Players |
全球细胞凋亡检测市场，按产品（检测试剂盒、试剂、微孔板、仪器）、技术（流式细胞术、细胞成像和分析系统、分光光度法、其他检测技术）、最终用户（制药和生物技术公司、医院和诊断实验室、学术和研究机构）、应用（药物发现和开发、临床和诊断应用、基础研究、干细胞研究）划分——行业趋势和预测到 2029 年。
细胞凋亡检测市场分析和规模
细胞凋亡检测有多种应用，包括调查研究、疾病发病机制、诊断和药物研发。在治疗方面，人们既希望通过引发细胞凋亡来清除不想要的不健康细胞，也希望通过避免非故意细胞凋亡来防止健康细胞死亡。
Data Bridge Market Research 分析，2021 年细胞凋亡检测市场规模为 33.157 亿美元，预计到 2029 年将达到 65.5841 亿美元，2022 年至 2029 年预测期内的复合年增长率为 8.9%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
细胞凋亡检测市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品（检测试剂盒、试剂、微孔板、仪器）、技术（流式细胞术、细胞成像和分析系统、分光光度法、其他检测技术）、最终用户（制药和生物技术公司、医院和诊断实验室、学术和研究机构）、应用（药物研发、临床和诊断应用、基础研究、干细胞研究） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories (U.S.), General Electric (U.S.), Sartorius AG (Germany), Danaher (U.S.), Geno Technology Inc. (U.S.), GeneCopoeia, Inc. (U.S.), Bio-Techne (U.S.), BioTek (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), Biotium (U.S.), Abcam plc (U.K.) and Creative Bioarray (U.S.) |
|
Market Opportunities |
|
Market Definition
Apoptosis assays cell-based apoptosis detection assays apoptosis, also known as programmed cell death, is a growth-limiting regulatory mechanism in which cells can kill themselves in response to extracellular signals due to irreversible cellular or DNA damage. Apoptosis inhibition causes cells to snub internal or external stimuli that would normally initiate apoptosis. This results in the survival and proliferation of damaged cells, increasing the likelihood of diseases such as cancer. As a result, many anti-cancer strategies in drug development focus on restoring apoptosis in order to cause cell death in these specific cell populations and shrink tumours.
Global Apoptosis Assays Market Dynamics
Drivers
- Rising advent of novel radionuclide tracers
The introduction of novel radionuclide tracers, such as caspase inhibitors and radiolabeled annexin V, has improved the proficiency of real-time monitoring of cellular death. For instance, ANNEXIN V kits have undergone various modifications, rising preference for radiolabeled ANNEXIN V kits. Controlling and understanding the mechanisms is involved in different steps of apoptosis aids in the novel drug discoveries. Also, the rise in the demand for caspase activity assays along with Bcl-2 protein family across pharmaceutical companies for cell death detection has boosted the market growth.
- Rise in innovative assay kits
Significant investment by market players in the development of innovative and affordable assay kits, coupled with a rising preference for apoptosis assay kits among users, is expected to contribute to the global market. Various kit manufacturers have developed an extensive product line that includes novel reagents that can improve cell-death detection and monitoring, because reagents are an essential component of apoptosis assay protocols. This is expected to boost the apoptosis assay market during the forecast period.
Opportunities
- Growing adoption of apoptosis assays
The high adoption of apoptosis assays in developing markets will create several opportunities that will lead to the growth of the apoptosis assays market in the forecast period due to factors such as the increasing prevalence of infectious and chronic diseases, rising funding for cancer research, and increasing cell-based research.
Restraints/Challenges
- Lack of skilled personnel for research and development
Dearth of skilled personnel for research and development of apoptosis assays. Cells can undergo apoptosis or necrosis due to the cells that die due to acute injury typically swell and burst and undergo necrosis. These all factors will obstruct the market's growth rate.
This apoptosis assays market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the apoptosis assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Apoptosis Assays Market Scope
The apoptosis assays market is segmented on the basis of product, technology, end user and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Assay Kits
- Caspase Assays
- Annexin V and Cell Permeability Assays
- DNA Fragmentation Assays
- Mitochondrial Assays
- Reagents
- Microplates
- Instruments
Technology
- Flow Cytometry
- Cell Imaging and Analysis Systems
- Spectrophotometry
- Other Detection Technologies
End User
- Pharmaceutical and Biotechnology Companies
- Hospital and Diagnostic Laboratories
- Academic and Research Institutes
Application
- Drug Discovery and Development
- Clinical and Diagnostic Applications
- Basic Research
- Stem Cell Research
Apoptosis Assays Market Regional Analysis/Insights
The apoptosis assays market is analysed and market size insights and trends are provided by country, product, technology, end user and application as referenced above.
The countries covered in the apoptosis assays market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the apoptosis assays market because of the rising research and development activities in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the growing demand from the healthcare industry and pharmaceutical industry.
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
细胞凋亡检测市场还为您提供每个国家/地区资本设备医疗保健支出增长、细胞凋亡检测市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对细胞凋亡检测市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。
竞争格局和细胞凋亡检测市场份额分析
细胞凋亡检测市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对细胞凋亡检测市场的关注有关。
细胞凋亡检测市场的一些主要参与者包括：
- 默克集团（德国）
- 赛默飞世尔科技公司（美国）
- BD（美国）
- Bio-Rad 实验室（美国）
- 通用电气（美国）
- Sartorius AG（德国）
- 丹纳赫（美国）
- Geno Technology Inc.（美国）
- GeneCopoeia, Inc.（美国）
- Bio-Techne (美国)
- BioTek (美国)
- PerkinElmer Inc.（美国）
- Promega 公司 (美国)
- Biotium（美国）
- Abcam plc（英国）
- Creative Bioray（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
